Page last updated: 2024-08-23
epirubicin and Infusion Site Adverse Event
epirubicin has been researched along with Infusion Site Adverse Event in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Borley, A; Dolan, G; Hanna, L; Roberts, R; Williams, EM | 1 |
Other Studies
1 other study(ies) available for epirubicin and Infusion Site Adverse Event
Article | Year |
---|---|
Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
Topics: Administration, Intravenous; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Injection Site Reaction; Middle Aged; Phlebitis; Prospective Studies | 2019 |